KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 41 filers reported holding KARUNA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $85,463,666 | -20.1% | 505,433 | +2.4% | 2.29% | -10.1% |
Q2 2023 | $107,021,330 | +19.4% | 493,527 | 0.0% | 2.55% | +19.0% |
Q1 2023 | $89,644,244 | +10.3% | 493,527 | +19.3% | 2.14% | +9.4% |
Q4 2022 | $81,304,233 | -12.6% | 413,762 | 0.0% | 1.96% | -18.6% |
Q3 2022 | $93,067,000 | +66.5% | 413,762 | -6.4% | 2.40% | +47.8% |
Q2 2022 | $55,904,000 | +1.9% | 441,893 | +2.2% | 1.63% | +17.8% |
Q1 2022 | $54,842,000 | -1.9% | 432,543 | +1.3% | 1.38% | +6.9% |
Q4 2021 | $55,916,000 | +16.6% | 426,843 | +8.9% | 1.29% | +28.2% |
Q3 2021 | $47,943,000 | +8.8% | 391,917 | +1.4% | 1.01% | +15.7% |
Q2 2021 | $44,071,000 | -0.6% | 386,618 | +4.8% | 0.87% | -9.9% |
Q1 2021 | $44,336,000 | +78.9% | 368,764 | +51.2% | 0.97% | +84.2% |
Q4 2020 | $24,783,000 | +31.3% | 243,950 | -0.1% | 0.52% | +9.6% |
Q3 2020 | $18,874,000 | -16.7% | 244,106 | +20.1% | 0.48% | -23.0% |
Q2 2020 | $22,661,000 | +74.9% | 203,312 | +13.0% | 0.62% | +16.0% |
Q1 2020 | $12,960,000 | -4.4% | 180,000 | 0.0% | 0.54% | +25.2% |
Q4 2019 | $13,561,000 | +130.6% | 180,000 | -50.1% | 0.43% | +82.9% |
Q3 2019 | $5,882,000 | -28.9% | 360,400 | -12.8% | 0.23% | -21.7% |
Q2 2019 | $8,278,000 | – | 413,500 | – | 0.30% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |